Eagle Pharmaceuticals (NASDAQ: EGRX) reported Q2 EPS of ($0.12). Revenue for the quarter came in at $48.71 million versus the consensus estimate of $53.87 million.

For earnings history and earnings-related data on Eagle Pharmaceuticals (EGRX) click here.